期刊文献+

联合检测抗CCP抗体、AKA与RF对类风湿性关节炎早期诊断的意义 被引量:12

Evaluation of anti-cyclic citrullinated peptide antibody、anti-keratin antibody and rheumatoid factor in diagnosis of early rheumatoid arthritis
下载PDF
导出
摘要 目的:探讨联合检测抗环瓜氨酸肽抗体(anti-CCP)、抗角蛋白抗体(AKA)与类风湿因子(RF)对类风湿性关节炎(RA)早期诊断的意义。方法:采用酶联免疫吸附法(ELASA)检测anti-CCP,采用间接免疫荧光法检测AKA,采用速率散射比浊法检测RF。结果:RF、anti-CCP、AKA在RA组的阳性率分别为88.75%、86.25%、67.50%,在对照组的阳性率分别为39.22%、15.69%、25.49%,实验组均高于对照组(P<0.01)。三者对诊断RA的灵敏度和特异度分别为anti-CCP:86.25%,88.73%;AKA:67.5%,81.69%;RF:88.75%,71.83%。三者联合检测特异度可达94.37%,阳性预测值可达92.60%。结论:anti-CCP具有较好的灵敏度和特异度;联合检测anti-CCP、AKA与RF可明显提高对类风湿性关节炎早期诊断的特异性。 Objective: To explore the diagnostic significance of rheumatoid factor(RF) anti-keratin antibody(AKA) and anti-cyclic citrullinated peptide antibody(anti-CCP) in rheumatoid arthritis(RA) patients. Methods: RF,anti-CCP and AKA were detected by rate nephelometry method, ELISA and indirect immunofluorescence (IIF) respectively from 80 patients with RA and 71 with non-RA. Results: The positive rates of RF, anti-CCP and AKA in RA group (88.75%, 86.25%, 67.50%) were higher than those in control group (39.22%, 15.69%, 25.49%) (P〈0.01). Especially, three of these autoantibodies can improve the specificity and the positive predictive value. Conclusion: Anti-CCP has relatively higher sensitivity and specificity in the diagnosis of early rheumatoid arthritis. The combined detection of anti-CCP, AKA and RF can improve the specificity of diagnosis of early RA.
出处 《中国医药导报》 CAS 2009年第19期32-34,共3页 China Medical Herald
关键词 类风湿性关节炎 抗环瓜氨酸肽抗体 抗角蛋白抗体 类风湿因子 Rheumatoid arthritis Anti-cyclic eitrullinated peptide antibody Anti-keratin antibody Rheumatoid factor
  • 相关文献

参考文献7

二级参考文献41

  • 1戴冽.抗环瓜氨酸肽抗体检测在关节病中的临床应用[J].中华内科杂志,2005,44(4):315-317. 被引量:22
  • 2李桂凤,高锋,王蕾.类风湿性关节炎中抗环瓜氨酸肽抗体的检测[J].现代检验医学杂志,2005,20(3):7-10. 被引量:14
  • 3Hssfeld W, Steiner G, Studnickabenke A, et al. Autoimmune response to the splicesome. A immunological link between rheumatoid arthritis,mixed connective tissue disease and systemic lupus erythematosus [J]. Arthrifis Rheum 1995,38 : 777.
  • 4Bizzaro N, Mazzanfi G,Tonuffi E, et al. Diagnostic accuracy of the anti-citrulline antiboby assay for rheumatoid arthritis[J]. Clin Chem,2001,Tun I 47(6) : 1089.
  • 5Eric JA, Kroot Ben AW, Ton, et al. The prognostic value of anti-cyclic citrullinate antibody in patients with recentonset rheumatoid arthritis[J]. Arthritis Rheum, 2000, 43(8):1831.
  • 6李鸿斌,中华医学杂志,2000年,80卷,20页
  • 7李小峰,中华风湿病杂志,1999年,3卷,208页
  • 8van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Antibodies to cyclic citrullinated peptide predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum, 2004,50: 709-715.
  • 9Schellekens G, Visser H, de Jong B, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000,43: 155-163.
  • 10Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum, 2000, 43: 1831-1835.

共引文献392

同被引文献103

引证文献12

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部